Modified Alzheimer’s drug may treat some forms of autism

A fusion of two existing drugs alleviates autism-like features in a mouse model of the condition, according to a new study¹.

The fusion drug, called NitroSynapsin, boosts social interest and alleviates some repetitive behaviors in mice missing one copy of the autism candidate gene MEF2C.

You need to login or register to bookmark/favorite this content.